語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Relationship between R&D and financi...
~
Nandy, Mithun.
FindBook
Google Book
Amazon
博客來
Relationship between R&D and financial performance in Indian pharmaceutical industry
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Relationship between R&D and financial performance in Indian pharmaceutical industry/ by Mithun Nandy.
作者:
Nandy, Mithun.
出版者:
Singapore :Springer Singapore : : 2022.,
面頁冊數:
xxxi, 202 p. :ill., digital ;24 cm.
內容註:
Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study.
Contained By:
Springer Nature eBook
標題:
Pharmaceutical industry - India. -
電子資源:
https://doi.org/10.1007/978-981-16-6921-7
ISBN:
9789811669217
Relationship between R&D and financial performance in Indian pharmaceutical industry
Nandy, Mithun.
Relationship between R&D and financial performance in Indian pharmaceutical industry
[electronic resource] /by Mithun Nandy. - Singapore :Springer Singapore :2022. - xxxi, 202 p. :ill., digital ;24 cm.
Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study.
The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the 'Pharmacy of the World' and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as 'Innovate in India and Serve to the World'. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View.
ISBN: 9789811669217
Standard No.: 10.1007/978-981-16-6921-7doiSubjects--Topical Terms:
799006
Pharmaceutical industry
--India.
LC Class. No.: HD9672.I52 / N35 2022
Dewey Class. No.: 338.4761510954
Relationship between R&D and financial performance in Indian pharmaceutical industry
LDR
:03262nmm a2200325 a 4500
001
2297082
003
DE-He213
005
20211203223552.0
006
m d
007
cr nn 008maaau
008
230324s2022 si s 0 eng d
020
$a
9789811669217
$q
(electronic bk.)
020
$a
9789811669200
$q
(paper)
024
7
$a
10.1007/978-981-16-6921-7
$2
doi
035
$a
978-981-16-6921-7
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
HD9672.I52
$b
N35 2022
072
7
$a
KC
$2
bicssc
072
7
$a
BUS000000
$2
bisacsh
072
7
$a
KC
$2
thema
082
0 4
$a
338.4761510954
$2
23
090
$a
HD9672.I52
$b
N176 2022
100
1
$a
Nandy, Mithun.
$3
3592314
245
1 0
$a
Relationship between R&D and financial performance in Indian pharmaceutical industry
$h
[electronic resource] /
$c
by Mithun Nandy.
260
$a
Singapore :
$b
Springer Singapore :
$b
Imprint: Palgrave Macmillan,
$c
2022.
300
$a
xxxi, 202 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study.
520
$a
The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the 'Pharmacy of the World' and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as 'Innovate in India and Serve to the World'. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View.
650
0
$a
Pharmaceutical industry
$z
India.
$3
799006
650
0
$a
Pharmaceutical industry
$z
India
$x
Finance.
$3
3592315
650
1 4
$a
Economics, general.
$3
2162671
650
2 4
$a
Accounting/Auditing.
$3
895555
650
2 4
$a
Market Research/Competitive Intelligence.
$3
2162287
650
2 4
$a
Asian Business.
$3
3236597
650
2 4
$a
Asian Economics.
$3
2191385
710
2
$a
SpringerLink (Online service)
$3
836513
773
0
$t
Springer Nature eBook
856
4 0
$u
https://doi.org/10.1007/978-981-16-6921-7
950
$a
Economics and Finance (SpringerNature-41170)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9438974
電子資源
11.線上閱覽_V
電子書
EB HD9672.I52 N35 2022
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入